CM
CLBT icon

Caption Management’s Cellebrite CLBT Stock Holding History

Caption Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.76M Buy
200,000
+50,000
+33% +$754K 0.02% 722
2025
Q4 		$2.7M Buy
+150,000
New +$2.69M 0.02% 726
2025
Q2 		– Sell
-40,000
Closed -$777K – 1497
2025
Q1 		$777K Buy
+40,000
New +$842K 0.01% 986
2024
Q4 		– Sell
-200,000
Closed -$3.37M – 1498
2024
Q3 		$3.37M Buy
+200,000
New +$2.97M 0.05% 403
2021
Q4 		– Sell
-100,000
Closed -$926K – 1641
2021
Q3 		$926K Buy
+100,000
New +$1.05M 0.01% 1041

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caption Management's CLBT Position: Q1 2026 in Review

Caption Management sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 48,000 shares — an estimated $723K sold.

Caption Management first reported a position in CLBT in Q3 2021 and held it in 4 quarters. The position peaked at $898K in Q3 2024. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Caption Management reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 48,000 Cellebrite shares in Q1 2026, an estimated $723K.
  • Caption Management first reported a position in Cellebrite in Q3 2021 and held it in 4 quarters.
  • Caption Management's Cellebrite position peaked at $898K in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.